Literature DB >> 9357508

Pericapillary fibrin cuffs in venous disease. A reappraisal.

M Van de Scheur1, V Falanga.   

Abstract

BACKGROUND: Over the last several years, a number of hypotheses have been proposed to explain the pathogenesis of venous ulceration. According to an early model suggested by Browse and Burnand, pericapillary fibrin cuffs, developing as a result of venous hypertension and extravasation of fibrinogen, act as a barrier to the diffusion of oxygen and nutrients; ultimately, tissue anoxia, cell death, and ulceration would follow. More recent hypotheses include the idea that macromolecules leaking from the vasculature trap growth factors and adhesion molecules, and the notion that white blood cells adhere to and damage endothelial cells in the microcirculation.
OBJECTIVE: To review the available evidence for or against a pathogenic role of fibrin cuffs, and hope to provide a useful perspective for this controversial topic.
METHODS: We have reviewed the different hypotheses for venous ulceration and the evidence for and against fibrin cuffs acting as a barrier.
CONCLUSIONS: Venous ulceration is likely to be the result of a number of distinct pathogenic events. Pericapillary fibrin cuffs remain a prominent feature, whether they act as a barrier, a marker for endothelial cell damage, or as part of an overall mechanism of macromolecular leakage and trapping.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357508     DOI: 10.1111/j.1524-4725.1997.tb00759.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  6 in total

Review 1.  Reactive oxygen species and bacterial biofilms in diabetic wound healing.

Authors:  Aksone Nouvong; Aaron M Ambrus; Ellen R Zhang; Lucas Hultman; Hilary A Coller
Journal:  Physiol Genomics       Date:  2016-10-07       Impact factor: 3.107

Review 2.  Management of leg ulcers.

Authors:  P K Sarkar; S Ballantyne
Journal:  Postgrad Med J       Date:  2000-11       Impact factor: 2.401

3.  Effectiveness of prostaglandin E1 in patients with mixed arterial and venous ulcers of the lower limbs.

Authors:  Giovanni De Caridi; Mafalda Massara; Francesco Stilo; Francesco Spinelli; Raffaele Grande; Lucia Butrico; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2014-08-05       Impact factor: 3.315

4.  Mesoglycan: clinical evidences for use in vascular diseases.

Authors:  Antonella Tufano; Claudia Arturo; Ernesto Cimino; Matteo Nicola Dario Di Minno; Mirko Di Capua; Anna Maria Cerbone; Giovanni Di Minno
Journal:  Int J Vasc Med       Date:  2010-08-31

5.  Molecular markers in patients with chronic wounds to guide surgical debridement.

Authors:  Harold Brem; Olivera Stojadinovic; Robert F Diegelmann; Hyacinth Entero; Brian Lee; Irena Pastar; Michael Golinko; Harvey Rosenberg; Marjana Tomic-Canic
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

6.  Protocol for a longitudinal cohort study: determination of risk factors for the development of first venous leg ulcer in people with chronic venous insufficiency, the VEINS (venous insufficiency in South Florida) cohort.

Authors:  Joshua S Mervis; Robert S Kirsner; Hadar Lev-Tov
Journal:  BMJ Open       Date:  2019-01-03       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.